comparemela.com

Latest Breaking News On - Bristol myers squib - Page 4 : comparemela.com

STOCK MARKET SNAPSHOT FOR 23/12/2023 | Hellenic Shipping News Worldwide

STOCK MARKET SNAPSHOT FOR 23/12/2023 | Hellenic Shipping News Worldwide
hellenicshippingnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from hellenicshippingnews.com Daily Mail and Mail on Sunday newspapers.

Bengaluru
Karnataka
India
Lululemon-athletica
Quincy-krosby
Kevin-gordon
Johannm-cherian
Berkshire-hathaway-brka
Maju-samuel
Reuters
Nasdaq
Federal-reserve

U.S. stocks mixed ahead of long Christmas weekend

STORY: U.S. stocks gyrated to a mixed close on Friday as investors headed into the long Christmas weekend. after digesting cooler-than-expected inflation data that firmed bets the Federal Reserve.

Phillip-colmar
Dick-sporting-goods
Nasdaq
Commerce-department
Managing-partner
Global-strategist
Federal-reserve
Foot-locker
Sporting-goods
Karuna-therapeutics
Bristol-myers-squib
Markets

S&P 500, Nasdaq set for higher open after soft inflation data; Nike slides

(Reuters) - The S&P 500 and the Nasdaq opened higher on Friday after a key inflation reading came in softer than expected, boosting recent investor .

China
Bengaluru
Karnataka
India
Chinese
Maju-samuel
Johannm-cherian
Berkshire-hathaway
Nasdaq
Federal-reserve
Reuters
Occidental-petroleum

Bristol Myers to buy Karuna Therapeutics for $14 billion

New York-based Bristol has been under pressure to expand its drug pipeline amid declining demand for two of its top drugs, blood cancer treatment Revlimid and blood thinner Eliquis, which face generic competition. "We expect KarXT to enhance our growth through the late 2020s and into the next decade," CEO Christopher Boerner said in a statement. Under the terms of the deal, Bristol would pay $330 a share in cash for Karuna, which represents a 53.4% premium to its last closing price.

Bengaluru
Karnataka
India
Manas-mishra
Arun-koyyur
Bristol-myers
Reuters
Bristol-myers-squib
Karuna-therapeutics
New-york-based
Bristol-myers-squibb
Mirati-therapeutics

vimarsana © 2020. All Rights Reserved.